Moleculin Biotech, Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 60855D309 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Armistice Capital, LLC 13G/A	4.99%	1,586,521	13G/A	8/14/2025 Event 6/30/2025
Armistice Capital, LLC	4.99%	1,586,521
Steven Boyd	4.99%	1,586,521

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q3	25	778 k	$413 k	$0
2025 Q2	24	390 k	$118 k	$0
2025 Q1	24	1.48 M	$1.44 M	$0
2024 Q4	22	465 k	$790 k	$0
2024 Q3	21	461 k	$1.31 M	$0
2024 Q2	19	314 k	$1.11 M	$0
2024 Q1	23	259 k	$1.53 M	$0